Joincare Pharmaceutical Group Industry Co Ltd (600380) — Capital Reinvestment Ratio
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.09 Billion) in capital expenditures (CN¥155.85 Million). See Joincare Pharmaceutical Group Industry C balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Joincare Pharmaceutical Group Industry Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Joincare Pharmaceutical Group Industry Co Ltd's Capital Reinvestment Ratio across 27 annual periods. Check how aggressively does Joincare Pharmaceutical Group Industry C reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. For live market cap and broader valuation context, see 600380 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥3.89 Billion | CN¥767.20 Million | ▼ -26.8% |
| 2024 | 0.27x | CN¥3.64 Billion | CN¥979.13 Million | ▼ -6.4% |
| 2023 | 0.29x | CN¥3.93 Billion | CN¥1.13 Billion | ▼ -0.3% |
| 2022 | 0.29x | CN¥3.98 Billion | CN¥1.15 Billion | ▼ -51.4% |
| 2021 | 0.59x | CN¥2.56 Billion | CN¥1.52 Billion | ▲ +116.2% |
| 2020 | 0.27x | CN¥3.02 Billion | CN¥830.41 Million | ▼ -9.7% |
| 2019 | 0.30x | CN¥2.31 Billion | CN¥703.20 Million | ▼ -15.2% |
| 2018 | 0.36x | CN¥1.83 Billion | CN¥655.02 Million | ▲ +39.6% |
| 2017 | 0.26x | CN¥1.87 Billion | CN¥480.68 Million | ▼ -15.5% |
| 2016 | 0.30x | CN¥1.64 Billion | CN¥499.99 Million | ▼ -35.3% |
| 2015 | 0.47x | CN¥1.26 Billion | CN¥594.33 Million | ▼ -43.7% |
| 2014 | 0.83x | CN¥979.46 Million | CN¥816.97 Million | ▼ -46.1% |
| 2013 | 1.55x | CN¥635.52 Million | CN¥983.83 Million | ▲ +31.7% |
| 2012 | 1.18x | CN¥734.36 Million | CN¥863.48 Million | ▲ +73.8% |
| 2011 | 0.68x | CN¥650.36 Million | CN¥440.12 Million | ▲ +28.0% |
| 2010 | 0.53x | CN¥1.11 Billion | CN¥584.47 Million | ▲ +4.4% |
| 2009 | 0.51x | CN¥605.66 Million | CN¥306.87 Million | ▲ +5.9% |
| 2008 | 0.48x | CN¥455.01 Million | CN¥217.71 Million | ▼ -16.7% |
| 2007 | 0.57x | CN¥429.26 Million | CN¥246.63 Million | ▼ -68.1% |
| 2006 | 1.80x | CN¥272.50 Million | CN¥490.19 Million | ▲ +77.6% |
| 2005 | 1.01x | CN¥363.13 Million | CN¥367.73 Million | ▲ +11.3% |
| 2004 | 0.91x | CN¥241.71 Million | CN¥219.90 Million | ▲ +41.7% |
| 2003 | 0.64x | CN¥172.25 Million | CN¥110.60 Million | ▲ +64.6% |
| 2002 | 0.39x | CN¥236.13 Million | CN¥92.09 Million | ▲ +25.5% |
| 2001 | 0.31x | CN¥223.79 Million | CN¥69.55 Million | ▼ -23.2% |
| 2000 | 0.40x | CN¥171.61 Million | CN¥69.46 Million | ▼ -9.6% |
| 1999 | 0.45x | CN¥109.82 Million | CN¥49.15 Million | — |